| Date Filed | Type | Description |
| 02/11/2022 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.7% stake in KalVista Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 0% stake in Eiger BioPharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/06/2021 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 4.9% stake in Eiger BioPharmaceuticals, Inc. |
| 02/12/2021 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 5.5% stake in Eiger BioPharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.9% stake in KalVista Pharmaceuticals, Inc. |
| 07/24/2020 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.7% stake in VERONA PHARMA PLC |
| 02/13/2020 |
SC 13G/A
| Vivo Ventures VI, LLC reports a 5.7% stake in KalVista Pharmaceuticals, Inc. |
| 11/18/2019 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 7.3% stake in Eiger BioPharmaceuticals, Inc. |
| 02/14/2019 |
SC 13D/A
| Vivo Ventures VI, LLC reports a 9.4% stake in Eiger BioPharmaceuticals, Inc. |
| 09/12/2018 |
SC 13G
| Vivo Ventures VI, LLC reports a 6% stake in KalVista Pharmaceuticals, Inc. |
| 11/01/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/05/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/01/2016 |
4
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc.|
Txns:
| Sold 2,299 shares
@ $13.55, valued at
$31.2k
Sold 17 shares
@ $13.55, valued at
$230.4 |
|
| 08/22/2016 |
4
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 186,136 shares
@ $16, valued at
$3M
Bought 1,364 shares
@ $16, valued at
$21.8k
|
|
| 04/25/2016 |
4
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 4 on Sagent Pharmaceuticals, Inc. |
| 04/01/2016 |
SC 13D
| Vivo Ventures VI, LLC reports a 23% stake in Eiger BioPharmaceuticals, Inc. |
| 03/28/2016 |
3
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
| 04/19/2013 |
SC 13G
| Durata Therapeutics, Inc. reports a 5.4% stake in Durata Therapeutics, Inc. |
| 04/19/2011 |
3
| Vivo Ventures VI, LLC (10% Owner) has filed a Form 3 on Sagent Holding Co. |
| 08/13/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |